Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-COMP vs R-CHOP in Elderly Patients With DLBCL/Follicular Lymphoma
NCT02012088Phase 2Completed
- Sponsor
- GELTAMO
- Start
- Oct 2013
- Primary completion
- Oct 2016
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin in diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), sponsored by GELTAMO. Started Oct 2013; status: completed.
02
Drugs
doxorubicin
03
Conditions
diffuse large B-cell lymphoma (DLBCL)follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT02012088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02012088.